Erratum: DNMT3B polymorphisms and cancer risk: A meta analysis of 24 case-control studies (Molecular Biology Reports (2012) 39 (4429-4437) DOI: 10.1007/s11033-011-1231-2);DNMT3B polymorphisms and cancer risk: A meta analysis of 24 case-control studies

Molecular Biology Reports

Volumn 39, Issue 4, 2012, Pages 4429-4437

  Zhu, Shimiao ^a   Zhang, Hui ^b   Tang, Yang ^a   Liu, Peicai ^a   Wang, Jianmin ^a  

^a Medical University   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; DNMT3B; Meta analysis; Polymorphism; Susceptivity

Indexed keywords

DNA METHYLTRANSFERASE 3B; DNA (CYTOSINE 5) METHYLTRANSFERASE;

ACUTE LEUKEMIA; AFRICAN; ALLELE; ARTICLE; ASIAN; BREAST CANCER; CANCER CLASSIFICATION; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLTRANSFERASE 3B GENE; DNA POLYMORPHISM; ESOPHAGUS CANCER; ETHNIC GROUP; ETHNICITY; EUROPEAN; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; ONCOGENE; PROSTATE CANCER; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; CAUCASIAN; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; NEOPLASM; PUBLISHING; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK FACTORS;

EID: 84861767486     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1617-9     Document Type: Erratum

References (37)

1. Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229
2. Okano M, Xie S, Li E (1998) Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 19:219-220
3. Bestor T, Laudano A, Mattaliano R, Ingram V (1988) Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol 203:971-983
4. Bestor TH (1992) Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain. EMBO J 11:2611-2617
5. Okano M, Bell DW, Haber DA, Li E (1999) DNA methyltransferases dnmt3a and dnmt3b are essential for de novo methylation and mammalian development. Cell 99:247-257
6. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA (1999) The human DNA methyltransferases (DNMTS) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 27:2291-2298
7. Fan H, Liu DS, Zhang SH, Hu JB, Zhang F, Zhao ZJ (2008) DNMT3B 579 G[T promoter polymorphism and risk of esophagus carcinoma in Chinese. World J Gastroenterol 14:2230-2234
8. Aung PP, Matsumura S, Kuraoka K, Kunimitsu K, Yoshida K, Matsusaki K, Nakayama H, Yasui W (2005) No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population. Oncol Rep 14:1151-1154
9. Shen H, Wang L, Spitz MR, Hong WK, Mao L, Wei Q (2002) A novel polymorphism in human cytosine DNA-methyltransferase-3b promoter is associated with an increased risk of lung cancer. Cancer Res 62:4992-4995
10. Lee SJ, Jeon HS, Jang JS, Park SH, Lee GY, Lee BH, Kim CH, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Cho YL, Jung TH, Park JY (2005) DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 26:403-409
11. Handoll HH (2006) Systematic reviews on rehabilitation interventions. Arch Phys Med Rehabil 87:875
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560
13. Hu J, Fan H, Liu D, Zhang S, Zhang F, Xu H (2010) DNMT3B promoter polymorphism and risk of gastric cancer. Dig Dis Sci 55:1011-1016
14. Wu Y, Lin JS (2007) DNA methyltransferase 3b promoter polymorphism and its susceptibility to primary hepatocellular carcinoma in the Chinese han nationality population: a case-control study. World J Gastroenterol 13:6082-6086
15. Jones JS, Amos CI, Pande M, Gu X, Chen J, Campos IM, Wei Q, Rodriguez-Bigas M, Lynch PM, Frazier ML (2006) DNMT3B polymorphism and hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiol Biomarkers Prev 15:886-891
16. Bao Q, He B, Pan Y, Tang Z, Zhang Y, Qu L, Xu Y, Zhu C, Tian F, Wang S (2011) Genetic variation in the promoter of DNMT3B is associated with the risk of colorectal cancer. Int J Colorectal Dis 26:1107-1112
17. Karpinski P, Myszka A, Ramsey D, Misiak B, Gil J, Laczmanska I, Grzebieniak Z, Sebzda T, Smigiel R, Stembalska A, Sasiadek MM (2010) Polymorphisms in methyl-group metabolism genes and risk of sporadic colorectal cancer with relation to the CpG island methylator phenotype. Cancer Epidemiol 34:338-344
18. de Vogel S, Wouters KA, Gottschalk RW, van Schooten FJ, de Goeij AF, de Bruine AP, Goldbohm RA, van den Brandt PA, Weijenberg MP, van Engeland M (2009) Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer. Cancer Epidemiol Biomarkers Prev 18:3086-3096
19. Li Y, Dai Y, Wu SL, Pei P, Cao XH, Pu DF (2005) The C46359T polymorphism of DNMT3B promoter gene and pathogenesis of acute leukemia. Chin J Intern Med 44:588-591
20. Ezzikouri S, El FA, Benazzouz M, Afifi R, El KL, Hassar M, Akil A, Pineau P, Benjelloun S (2009) Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population. Infect Genet Evol 9:877-881
21. Liu Z, Wang L, Wang LE, Sturgis EM, Wei Q (2008) Polymorphisms of the DNMT3B gene and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett 268:158-165
22. Fan H, Zhang F, Hu J, Liu D, Zhao Z (2008) Promoter polymorphisms of DNMT3B and the risk of colorectal cancer in Chinese: a case-control study. J Exp Clin Cancer Res 27:24
23. Wang YM, Wang R, Wen DG, Li Y, Guo W, Wang N, Wei LZ, He YT, Chen ZF, Zhang XF, Zhang JH (2005) Single nucleotide polymorphism in DNA methyltransferase 3B promoter and its association with gastric cardiac adenocarcinoma in North China. World J Gastroenterol 11:3623-3627
24. Iacopetta B, Heyworth J, Girschik J, Grieu F, Clayforth C, Fritschi L (2009) The MTHFR C677T and DeltaDNMT3b C-149T polymorphisms confer different risks for right-and left-sided colorectal cancer. Int J Cancer 125:84-90
25. Reeves SG, Mossman D, Meldrum CJ, Kurzawski G, Suchy J, Lubinski J, Scott RJ (2008) The -149C[T SNP within the DeltaDNMT3b gene, is not associated with early disease onset in hereditary non-polyposis colorectal cancer. Cancer Lett 265: 39-44
26. Singal R, Das PM, Manoharan M, Reis IM, Schlesselman JJ (2005) Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk. Oncol Rep 14:569-573
27. Montgomery KG, Liu MC, Eccles DM, Campbell IG (2004) The DNMT3B C-[T promoter polymorphism and risk of breast cancer in a British population: a case-control study. Breast Cancer Res 6:R390-R394
28. Guo X, Zhang L, Wu M, Wang N, Liu Y, Er L, Wang S, Gao Y, Yu W, Xue H, Xu Z, Wang S (2010) Association of the DNMT3B polymorphism with colorectal adenomatous polyps and adenocarcinoma. Mol Biol Rep 37:219-225
29. Hong YS, Lee HJ, You CH, Roh MS, Kwak JY, Lee MJ, Kim JY (2007) DNMT3B 39179GT polymorphism and the risk of adenocarcinoma of the colon in Koreans. Biochem Genet 45: 155-163
30. Chang KP, Hao SP, Tsang NM, Chang YL, Cheng MH, Liu CT, Lee YS, Tsai CL, Lee TJ, Wang TH, Tsai CN (2008) Gene expression and promoter polymorphisms of DNA methyltransferase 3B in nasopharyngeal carcinomas in Taiwanese people: a case-control study. Oncol Rep 19:217-222
31. Chang KP, Hao SP, Liu CT, Cheng MH, Chang YL, Lee YS, Wang TH, Tsai CN (2007) Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study. Oral Oncol 43:345-351
32. Srivastava K, Srivastava A, Mittal B (2010) DNMT3B-579 G[T promoter polymorphism and risk of gallbladder carcinoma in North Indian population. J Gastrointest Cancer 41:248-253
33. Zhou W, Jiang Z, Liu N, Xu F, Wen P, Liu Y, Zhong W, Song X, Chang X, Zhang X, Wei G, Yu J (2009) Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas. J Cancer Res Clin Oncol 135:91-102
34. Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H (2001) Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 97:1172-1179
35. Wang L, Rodriguez M, Kim ES, Xu Y, Bekele N, El-Naggar AK, Hong WK, Mao L, Oh YW (2004) A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer. Int J Oncol 25:993-999
36. Xu B, Niu XB, Wang ZD, Cheng W, Tong N, Mi YY, Min ZC, Tao J, Li PC, Zhang W, Wu HF, Zhang ZD, Wang ZJ, Hua LX, Feng NH, Wang XR: IL-6 -174G[C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls. Mol Biol Rep 38:2589-2596
37. Huang Q, Wang C, Qiu LJ, Shao F, Yu JH (2011) IL-8-251A[T polymorphism is associated with breast cancer risk: a metaanalysis. J Cancer Res Clin Oncol 137:1147-1150